Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.19.3.a.u2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Dec. 31, 2019
Dec. 31, 2018
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]    
Net revenues $ 10,578,016 $ 6,371,809
Cost of sales 3,308,921 1,727,729
Gross profit 7,269,095 4,644,080
Operating expenses:    
Research and development 5,299,974 2,361,823
Selling, general and administrative 3,753,514 3,293,984
Total operating expenses 9,053,488 5,655,807
Operating loss (1,784,393) (1,011,727)
Non-operating (expenses) income:    
Interest expense (1,141,425) (1,278,423)
Change in fair value of derivative liabilities (394,000) 225,000
Foreign currency transaction loss (70,009) (17,544)
Other income, net 7,983 26,394
Total non-operating expenses (1,597,451) (1,044,573)
Loss before income taxes (3,381,844) (2,056,300)
Income tax (benefit) expense (76,743) 92,498
Net loss $ (3,305,101) $ (2,148,798)
Net loss per basic and diluted common share outstanding $ (0.05) $ (0.03)
Basic and diluted weighted average common shares outstanding 65,038,511 62,553,791